If anyone on this board has not watched this, they need to. Carl Stubbings' excitement is palpable about the recent future developments coming to Benitec to the point where he looks like he will pee his pants. His excitement is most notable around both the success of TT-034, as well as the potential implications for Hep B, and ultimately Benitec's whole platform. Carl seems to insinuate that efficacy data may POSSIBLY be available publicly in the next cohort, given his excitement over Big Pharma discussions that seem to revolve over efficacy data and the validation this brings to Benitec's technology.
Hold onto your hats, people! The next six months will be interesting indeed!
Market Data 
Markets 
AI
